Difference between revisions of "Template:Lipid signaling"

From blackwiki
Jump to navigation Jump to search
imported>Medgirl131
m
imported>Boghog
(add child navboxes and eliminated distracting bolding)
Line 6: Line 6:
  
 
| group1 = Extracellular
 
| group1 = Extracellular
| list1 =  
+
| list1 = {{Navbox|child
* '''Eicosanoids:''' ''Classic:'' [[Eoxin]]s
+
 
 +
    | group1 = {{nobold|''Eicosanoids''}}
 +
    | list1 =
 +
 
 +
* ''Classic:'' [[Eoxin]]s;
 
* [[Leukotriene]]s ([[Leukotriene receptor|LTR]])
 
* [[Leukotriene]]s ([[Leukotriene receptor|LTR]])
 
* [[Prostacyclin]] ([[Prostacyclin receptor|IPR]])
 
* [[Prostacyclin]] ([[Prostacyclin receptor|IPR]])
 
* [[Prostaglandin]]s ([[Prostaglandin receptor|PGR]])
 
* [[Prostaglandin]]s ([[Prostaglandin receptor|PGR]])
* [[Thromboxane]] ([[Thromboxane receptor|TXR]]); ''Nonclassic:'' [[Epoxyeicosatrienoic acid|EET]]s
+
* [[Thromboxane]] ([[Thromboxane receptor|TXR]])
 +
* ''Nonclassic:'' [[Epoxyeicosatrienoic acid|EET]]s
 
* [[Endocannabinoid]]s ([[Cannabinoid receptor|CBR]])
 
* [[Endocannabinoid]]s ([[Cannabinoid receptor|CBR]])
 
* [[Epi-lipoxin]]s ([[Formyl peptide receptor 2|FPR2]])
 
* [[Epi-lipoxin]]s ([[Formyl peptide receptor 2|FPR2]])
Line 18: Line 23:
 
* [[Lipoxin]]s ([[Formyl peptide receptor 2|FPR2]])
 
* [[Lipoxin]]s ([[Formyl peptide receptor 2|FPR2]])
 
* [[Oxoeicosanoid]]s ([[Oxoeicosanoid receptor|OXER]])
 
* [[Oxoeicosanoid]]s ([[Oxoeicosanoid receptor|OXER]])
* [[Resolvin]]s ([[Formyl peptide receptor 2|FPR2]]); '''Lysophospholipids:''' [[Lysophosphatidic acid|LPA]] ([[Lysophosphatidic acid receptor|LPAR]])
+
* [[Resolvin]]s ([[Formyl peptide receptor 2|FPR2]])
* [[Sphingosine-1-phosphate|S1P]] ([[Sphingosine-1-phosphate receptor|S1PR]]); '''Steroids:''' [[Bile acid]]s ([[G protein-coupled bile acid receptor|GPBAR]])
+
 
 +
    | group2 = {{nobold|''Lysophospholipids''}}
 +
    | list2 =
 +
* [[Lysophosphatidic acid|LPA]] ([[Lysophosphatidic acid receptor|LPAR]])
 +
* [[Sphingosine-1-phosphate|S1P]] ([[Sphingosine-1-phosphate receptor|S1PR]])
 +
 
 +
    | group3 = {{nobold|''Steroids''}}
 +
    | list3 =
 +
* [[Bile acid]]s ([[G protein-coupled bile acid receptor|GPBAR]])
 
* [[Neurosteroid]]s
 
* [[Neurosteroid]]s
* [[Pheromone]]s ([[Vomeronasal receptor|VNR]]); '''Others:''' [[Platelet-activating factor|PAF]] ([[Platelet-activating factor receptor|PAFR]])
+
* [[Pheromone]]s ([[Vomeronasal receptor|VNR]])
 +
 
 +
    | group4 = {{nobold|''Others''}}
 +
    | list4 =
 +
* [[Platelet-activating factor|PAF]] ([[Platelet-activating factor receptor|PAFR]])
 
* [[Retinal]] ([[Rhodopsin|RHO]])
 
* [[Retinal]] ([[Rhodopsin|RHO]])
 
+
}}
 
| group2 = Intracellular
 
| group2 = Intracellular
 
| list2 = {{Navbox subgroup
 
| list2 = {{Navbox subgroup
Line 30: Line 47:
 
   | group1 = [[Nuclear receptor]]
 
   | group1 = [[Nuclear receptor]]
 
   | list1 =  
 
   | list1 =  
* '''Steroids:''' ''Sex steroids:'' [[Androgen]]s ([[Androgen receptor|AR]])
+
* ''Steroids:'' ''Sex steroids:'' [[Androgen]]s ([[Androgen receptor|AR]])
 
* [[Estrogen]]s ([[Estrogen receptor|ER]])
 
* [[Estrogen]]s ([[Estrogen receptor|ER]])
 
* [[Progestogen]]s ([[Progesterone receptor|PR]]); ''Corticosteroids:'' [[Glucocorticoid]]s ([[Glucocorticoid receptor|GR]])
 
* [[Progestogen]]s ([[Progesterone receptor|PR]]); ''Corticosteroids:'' [[Glucocorticoid]]s ([[Glucocorticoid receptor|GR]])
 
* [[Mineralocorticoid]]s ([[Mineralocorticoid receptor|MR]]); ''Others:'' [[Bile acid]]s ([[Farnesoid X receptor|FXR]])
 
* [[Mineralocorticoid]]s ([[Mineralocorticoid receptor|MR]]); ''Others:'' [[Bile acid]]s ([[Farnesoid X receptor|FXR]])
* [[Calcitriol]] ([[Vitamin D receptor|VDR]]); '''Others:''' [[Eicosanoid]]s ([[Peroxisome proliferator-activated receptor|PPAR]])
+
* [[Calcitriol]] ([[Vitamin D receptor|VDR]]); ''Others:'' [[Eicosanoid]]s ([[Peroxisome proliferator-activated receptor|PPAR]])
 
* [[Free fatty acid]]s ([[Peroxisome proliferator-activated receptor|PPAR]])
 
* [[Free fatty acid]]s ([[Peroxisome proliferator-activated receptor|PPAR]])
 
* [[Retinoic acid]] ([[Retinoic acid receptor|RAR]], [[Retinoid X receptor|RXR]])
 
* [[Retinoic acid]] ([[Retinoic acid receptor|RAR]], [[Retinoid X receptor|RXR]])
Line 40: Line 57:
 
   | group2 = [[Second messenger system|Second messenger]]
 
   | group2 = [[Second messenger system|Second messenger]]
 
   | list2 =  
 
   | list2 =  
* '''General:''' [[Arachidonic acid]]
+
* ''General:'' [[Arachidonic acid]]
 
* [[Diacylglycerol|DAG]] ([[Protein kinase C|PKC]], [[TRPC]])
 
* [[Diacylglycerol|DAG]] ([[Protein kinase C|PKC]], [[TRPC]])
 
* [[Inositol trisphosphate|IP<sub>3</sub>]] ([[Inositol trisphosphate receptor|IP<sub>3</sub>R]], [[Ryanodine receptor|RyR]])
 
* [[Inositol trisphosphate|IP<sub>3</sub>]] ([[Inositol trisphosphate receptor|IP<sub>3</sub>R]], [[Ryanodine receptor|RyR]])
 
* [[Phosphatidic acid]]
 
* [[Phosphatidic acid]]
* '''Phosphoinositides:''' [[Phosphatidylinositol 4,5-bisphosphate|PIP<sub>2</sub>]] ([[Inward-rectifier potassium ion channel|IRK]]s)
+
* ''Phosphoinositides:'' [[Phosphatidylinositol 4,5-bisphosphate|PIP<sub>2</sub>]] ([[Inward-rectifier potassium ion channel|IRK]]s)
 
* [[Phosphatidylinositol (3,4,5)-trisphosphate|PIP<sub>3</sub>]] ([[Protein kinase B|PKB/Akt]], [[Bruton's tyrosine kinase|Btk]], [[Phosphoinositide-dependent kinase-1|PDPK1]])
 
* [[Phosphatidylinositol (3,4,5)-trisphosphate|PIP<sub>3</sub>]] ([[Protein kinase B|PKB/Akt]], [[Bruton's tyrosine kinase|Btk]], [[Phosphoinositide-dependent kinase-1|PDPK1]])
* [[Phosphatidylinositol 3,4-bisphosphate|PtdIns(3,4)P<sub>2</sub>]] ([[Protein kinase B|PKB/Akt]], [[Phosphoinositide-dependent kinase-1|PDPK1]]); '''Sphingolipids:''' [[Ceramide-1-phosphate|C1P]]
+
* [[Phosphatidylinositol 3,4-bisphosphate|PtdIns(3,4)P<sub>2</sub>]] ([[Protein kinase B|PKB/Akt]], [[Phosphoinositide-dependent kinase-1|PDPK1]]); ''Sphingolipids:'' [[Ceramide-1-phosphate|C1P]]
 
* [[Ceramide]] ([[Ceramide-activated protein phosphatase|CAPP]]s, [[KSR1]], [[Protein kinase C zeta type|PKCζ]], [[Cathepsin D|CTSD]])
 
* [[Ceramide]] ([[Ceramide-activated protein phosphatase|CAPP]]s, [[KSR1]], [[Protein kinase C zeta type|PKCζ]], [[Cathepsin D|CTSD]])
 
* [[Glucosylceramide]]s
 
* [[Glucosylceramide]]s
Line 54: Line 71:
  
 
| group3 = Precursors
 
| group3 = Precursors
| list3 =  
+
| list3 = {{Navbox|child
* '''General:''' [[Fatty acid]]s ([[Omega-3 fatty acid|ω-3]], [[Omega-6 fatty acid|ω-6]]); '''Steroids:''' [[Squalene]]
+
 
 +
    | group1 = {{nobold|''General''}}
 +
    | list1 =
 +
* [[Fatty acid]]s ([[Omega-3 fatty acid|ω-3]], [[Omega-6 fatty acid|ω-6]])
 +
 
 +
    | group2 = {{nobold|''Steroids''}}
 +
    | list2 =
 +
* [[Squalene]]
 
* [[Lanosterol]]
 
* [[Lanosterol]]
 
* [[Cholesterol]]
 
* [[Cholesterol]]
 
+
}}
 
| belowstyle = padding: 0px;
 
| belowstyle = padding: 0px;
 
| below = {{Signal transduction navs}}
 
| below = {{Signal transduction navs}}

Revision as of 16:10, 6 July 2015